Connect Biopharma Holdings Limited (CNTB)
$0.87-1.14%Close
SELLCRISIS · day 26
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $55M
- Beta
- -0.22
- P/E (TTM)
- -1.03
- Short % float
- 22.67%
- Days to cover
- 1.0
- SI change
- +26.2%
- 1W
- -6.45%
- 1M
- -57.77%
- vs SPY 1W
- -7.61%
- vs SPY 1M
- -60.76%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on CNTB?
- LOPJLB’s latest quantitative signal on Connect Biopharma Holdings Limited (CNTB) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is CNTB in?
- Connect Biopharma Holdings Limited (CNTB) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Connect Biopharma Holdings Limited (CNTB) do?
- Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company dedicated to discovering and advancing immune modulators. Its primary objective is to develop treatments for serious autoimmune diseases and various inflammatory conditions. The company's lead investigational therapy is CBP-201, an anti-interleukin-4 receptor alpha antibody. This candidate is currently in Phase IIb…